Analysts expect over 2018 rising revenue Celgene

Tomorrow the American company Celgene will publish its past quarter's results. For this year Celgene 's revenue will be around 12,99 billion USD. This is according to the average of the analysts' estimates. This is hugely more than 2016's revenue of 11,23 billion USD.

Historical revenues and results Celgene plus estimates 2018

The analysts expect for 2018 a net profit of 5,98 billion USD. The majority of the analysts expects for this year a profit per share of 7,38 USD. So the price/earnings-ratio equals 14,17.

For this year analysts don't expect the company to pay a dividend.The average dividend yield of the biotech companies equals a good 1,75 percent.

Newest target prices around 117 USD

Credit Suisse , KBC Securities and Cantor Fitzgerald recently provided recommendations for the stock.

Celgene 's market value equals around 82,24 billion .

At 21.57 the stock trades 1,32 percent lower at 104,55 USD.

Historical stock prices Celgene

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.